| Product Code: ETC11389271 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The Republic of North Macedonia saw a steady increase in anticoagulants import shipments in 2024, with top exporting countries including Slovenia, Germany, Metropolitan France, Italy, and the UK. The market displayed a low concentration in Herfindahl-Hirschman Index (HHI) in 2023, which further decreased in 2024. The compound annual growth rate (CAGR) between 2020 and 2024 stood at 3.22%, showing a positive trend. Moreover, the growth rate from 2023 to 2024 was notably higher at 3.98%, indicating a promising outlook for the anticoagulants market in North Macedonia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Republic of Macedonia Anticoagulants Market Overview |
3.1 Republic of Macedonia Country Macro Economic Indicators |
3.2 Republic of Macedonia Anticoagulants Market Revenues & Volume, 2021 & 2031F |
3.3 Republic of Macedonia Anticoagulants Market - Industry Life Cycle |
3.4 Republic of Macedonia Anticoagulants Market - Porter's Five Forces |
3.5 Republic of Macedonia Anticoagulants Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Republic of Macedonia Anticoagulants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Republic of Macedonia Anticoagulants Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Republic of Macedonia Anticoagulants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Republic of Macedonia Anticoagulants Market Trends |
6 Republic of Macedonia Anticoagulants Market, By Types |
6.1 Republic of Macedonia Anticoagulants Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Republic of Macedonia Anticoagulants Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Republic of Macedonia Anticoagulants Market Revenues & Volume, By Direct Oral Anticoagulants, 2021 - 2031F |
6.1.4 Republic of Macedonia Anticoagulants Market Revenues & Volume, By Vitamin K Antagonists, 2021 - 2031F |
6.1.5 Republic of Macedonia Anticoagulants Market Revenues & Volume, By Heparin, 2021 - 2031F |
6.2 Republic of Macedonia Anticoagulants Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Republic of Macedonia Anticoagulants Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Republic of Macedonia Anticoagulants Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Republic of Macedonia Anticoagulants Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Republic of Macedonia Anticoagulants Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.3 Republic of Macedonia Anticoagulants Market Revenues & Volume, By Atrial Fibrillation, 2021 - 2031F |
6.3.4 Republic of Macedonia Anticoagulants Market Revenues & Volume, By Pulmonary Embolism, 2021 - 2031F |
7 Republic of Macedonia Anticoagulants Market Import-Export Trade Statistics |
7.1 Republic of Macedonia Anticoagulants Market Export to Major Countries |
7.2 Republic of Macedonia Anticoagulants Market Imports from Major Countries |
8 Republic of Macedonia Anticoagulants Market Key Performance Indicators |
9 Republic of Macedonia Anticoagulants Market - Opportunity Assessment |
9.1 Republic of Macedonia Anticoagulants Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Republic of Macedonia Anticoagulants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Republic of Macedonia Anticoagulants Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Republic of Macedonia Anticoagulants Market - Competitive Landscape |
10.1 Republic of Macedonia Anticoagulants Market Revenue Share, By Companies, 2024 |
10.2 Republic of Macedonia Anticoagulants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |